Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Idiopathic Pulmonary Fibrosis
Related studies linked through entity extraction aliases.
68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE4
Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- TERMINATED
- Phase
- PHASE2
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl.
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
- Status
- TERMINATED
- Phase
- PHASE2
Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1
Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.
- Status
- UNKNOWN
- Phase
- N/A
Microaspiration in Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
- Status
- COMPLETED
- Phase
- N/A
Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients
- Status
- COMPLETED
- Phase
- NA
Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study
- Status
- COMPLETED
- Phase
- N/A
Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
- Status
- UNKNOWN
- Phase
- N/A
Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- N/A
Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
- Status
- TERMINATED
- Phase
- PHASE3